Wells Fargo Maintains Equal-Weight on Globus Medical, Lowers Price Target to $58
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Vik Chopra has maintained an Equal-Weight rating on Globus Medical (NYSE:GMED) and lowered the price target from $63 to $58.
September 15, 2023 | 3:39 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on Globus Medical and lowered the price target from $63 to $58.
The lowering of the price target by Wells Fargo indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100